000 01627cam  2200337zi 4500
0019.929289
003CaOODSP
00520240102162558
006m     o  d f      
007cr cn|||||||||
008231023t20232023oncdb   ob   f000 0 eng d
020 |a9780660684116
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-347/2023E-PDF
24500|aTrends in HIV pre-exposure prophylaxis [HIV-PrEP] use in nine Canadian provinces, 2019-2022.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023.
264 4|c©2023
300 |a1 online resource (1 page) : |bcharts, map
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Tendances de l’utilisation de la prophylaxie préexposition au VIH [VIH-PPrE] dans neuf provinces canadiennes, 2019-2022.
500 |aCaption title.
504 |aIncludes bibliographical references.
650 0|aHIV infections|zCanada|xPrevention.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tTendances de l’utilisation de la prophylaxie préexposition au VIH [VIH-PPrE] dans neuf provinces canadiennes, 2019-2022|w(CaOODSP)9.929290
85640|qPDF|s429 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-347-2023-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/diseases-conditions/trends-pre-exposure-prophylaxis-use-in-9-canadian-provinces-2019-2022-infographic.html